MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

08 Aug 2022 Evaluate
The sales for the June 2022 quarter moved up 32.46% to Rs. 2323.32 millions as compared to Rs. 1754.02 millions during the corresponding quarter last year.The Profit  for the quarter ended June 2022 of  Rs. 201.55  millions  grew by 96.79% from Rs. 102.42 millions.Operating profit for the quarter ended June 2022 rose to 320.78 millions as compared to 185.30 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2323.32 1754.02 32.46 2323.32 1754.02 32.46 8056.00 8135.63 -0.98
Other Income 41.14 28.99 41.91 41.14 28.99 41.91 147.58 128.41 14.93
PBIDT 320.78 185.30 73.11 320.78 185.30 73.11 1009.33 1483.12 -31.95
Interest 1.86 2.66 -30.08 1.86 2.66 -30.08 9.47 10.93 -13.36
PBDT 318.92 182.64 74.62 318.92 182.64 74.62 999.86 1472.19 -32.08
Depreciation 45.92 47.61 -3.55 45.92 47.61 -3.55 169.49 201.26 -15.79
PBT 273.00 135.03 102.18 273.00 135.03 102.18 830.37 1270.93 -34.66
TAX 71.45 32.61 119.10 71.45 32.61 119.10 214.43 337.90 -36.54
Deferred Tax -5.29 -9.06 -41.61 -5.29 -9.06 -41.61 -11.86 -10.38 14.26
PAT 201.55 102.42 96.79 201.55 102.42 96.79 615.94 933.03 -33.98
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 13.81 10.56 30.69 13.81 10.56 30.69 12.53 18.23 -31.27
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..